Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.

Area of Science:

• Neuroscience
• Cell Biology
• Mitochondrial Biology

Background:

• Neural stem cells (NSCs) show therapeutic potential for neurodegenerative diseases (NDs).
• NSC differentiation is crucial for therapeutic efficacy.
• Melatonin's role in NSC differentiation and mitochondrial involvement requires further investigation.

Purpose of the Study:

• To investigate the impact of melatonin on NSC proliferation and differentiation.
• To determine if melatonin's effects on NSCs are mediated by mitochondrial activity.
• To assess melatonin's potential to improve NSC engraftment in ND models.

Main Methods:

• Assessed NSC proliferation and differentiation markers.
• Measured mitochondrial structural and functional parameters (mass, DNA, respiration, membrane potential, ATP synthesis).
• Evaluated oxidative stress indicators and NSC transplant engraftment in an ND mouse model.

Main Results:

• Melatonin (25 μM) induced NSC differentiation into neurons and oligodendrocytes.
• Melatonin enhanced mitochondrial mass, DNA, complex activity, respiration, membrane potential, and ATP synthesis.
• Melatonin mitigated oxidative stress and improved NSC engraftment in an ND mouse model.

Conclusions:

• Melatonin promotes NSC differentiation and function via mitochondrial activity.
• Pretreating NSCs with melatonin could be a viable strategy for neurodegenerative disease therapy.
• Combined therapy of melatonin-pretreated NSCs may restore neuronal populations in Parkinson's and Alzheimer's disease models.